CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 76% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
Country • Select Country
    Entity • The products and services listed on this website are not available to US residents.
    English العَرَبِيَّة Deutsch ελληνικά Español Français Italiano Magyar Nederlands Polski Română Русский 简体中文 繁體中文

    Trade Thermo Fisher Scientific - TMO CFD

    496.85
    0.78%
    0.24
    Low: 497.38
    High: 502.92
    Market Trading Hours* (UTC) Open now
    Closes on Wednesday at 20:00

    Mon - Fri: 13:30 - 20:00

    • Summary
    • Historical Data
    • Events
    • Income Statement
    • Balance Sheet
    • Cash Flow
    • Ownership
    Trading Conditions
    Spread 0.24
    Long position overnight fee

    Long position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee -0.026151 %
    Charges from full value of position ($-4.97)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		-0.026151%
    Short position overnight fee

    Short position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee 0.003929 %
    Charges from full value of position ($0.75)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		0.003929%
    Overnight fee time 21:00 (UTC)
    Min traded quantity 1
    Currency USD
    Margin 5%
    Stock exchange United States of America
    Commission on trade 0%

    *Information provided by Capital.com

    Thermo Fisher Scientific Inc ESG Risk Ratings

    High Medium Low Negligible

    ‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.

    More ESG coverage

    Key Stats
    Prev. Close* 501.29
    Open* 502.02
    1-Year Change* -2.47%
    Day's Range* 497.38 - 502.92
    52 wk Range 475.77-609.85
    Average Volume (10 days) 1.07M
    Average Volume (3 months) 30.20M
    Market Cap 205.19B
    P/E Ratio 36.33
    Shares Outstanding 385.95M
    Revenue 43.52B
    EPS 14.64
    Dividend (Yield %) 0.26333
    Beta 0.78
    Next Earnings Date Oct 24, 2023

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Change Change (%) Open High Low
    Sep 26, 2023 501.29 -0.95 -0.19% 502.24 505.54 500.77
    Sep 25, 2023 505.44 5.40 1.08% 500.04 505.93 499.04
    Sep 22, 2023 502.21 -0.04 -0.01% 502.25 506.76 500.09
    Sep 21, 2023 501.16 0.38 0.08% 500.78 503.57 498.76
    Sep 20, 2023 504.52 -4.55 -0.89% 509.07 511.20 503.15
    Sep 19, 2023 508.33 5.92 1.18% 502.41 509.20 502.40
    Sep 18, 2023 507.43 -5.23 -1.02% 512.66 513.62 506.60
    Sep 15, 2023 515.08 0.13 0.03% 514.95 533.54 508.70
    Sep 14, 2023 515.46 2.90 0.57% 512.56 517.80 504.95
    Sep 13, 2023 510.59 11.45 2.29% 499.14 525.84 497.06
    Sep 12, 2023 510.70 -3.20 -0.62% 513.90 513.92 509.00
    Sep 11, 2023 514.53 -0.68 -0.13% 515.21 517.43 510.69
    Sep 8, 2023 517.84 -8.82 -1.67% 526.66 531.89 512.43
    Sep 7, 2023 531.19 -2.79 -0.52% 533.98 537.66 530.33
    Sep 6, 2023 536.31 -3.98 -0.74% 540.29 543.30 535.43
    Sep 5, 2023 541.56 -16.05 -2.88% 557.61 557.95 540.70
    Sep 1, 2023 556.52 -3.12 -0.56% 559.64 564.64 555.56
    Aug 31, 2023 556.25 -2.10 -0.38% 558.35 562.46 556.25
    Aug 30, 2023 558.61 6.42 1.16% 552.19 562.12 550.53
    Aug 29, 2023 555.00 9.52 1.75% 545.48 557.02 541.71

    Thermo Fisher Scientific Events

    Time (UTC) Country Event
    Tuesday, October 24, 2023

    Time (UTC)

    12:30

    Country

    US

    Event

    Q3 2023 Thermo Fisher Scientific Inc Earnings Release
    Q3 2023 Thermo Fisher Scientific Inc Earnings Release

    Forecast

    -

    Previous

    -
    Tuesday, January 30, 2024

    Time (UTC)

    13:30

    Country

    US

    Event

    Q4 2023 Thermo Fisher Scientific Inc Earnings Release
    Q4 2023 Thermo Fisher Scientific Inc Earnings Release

    Forecast

    -

    Previous

    -
    View all events
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total revenue 44915 39211 32218 25542 24358
    Revenue 44915 39211 32218 25542 24358
    Cost of Revenue, Total 25944 19573 16231 14213 13499
    Gross Profit 18971 19638 15987 11329 10859
    Total Operating Expense 36548 29950 24424 21132 20575
    Selling/General/Admin. Expenses, Total 8934 7816 6940 6082 6028
    Research & Development 1471 1406 1181 1003 967
    Unusual Expense (Income) 140 1108 89 -167 79
    Operating Income 8367 9261 7794 4410 3783
    Interest Income (Expense), Net Non-Operating -548 -427 -569 -408 -528
    Other, Net 16 7 68 7
    Net Income Before Taxes 7835 8841 7225 4070 3262
    Net Income After Taxes 7132 7732 6375 3704 3055
    Net Income Before Extra. Items 6950 7725 6375 3704 3055
    Total Extraordinary Items 0 -8 -117
    Net Income 6950 7725 6375 3696 2938
    Income Available to Common Excl. Extra. Items 6950 7725 6375 3704 3055
    Income Available to Common Incl. Extra. Items 6950 7725 6375 3696 2938
    Diluted Net Income 6950 7725 6375 3696 2938
    Diluted Weighted Average Shares 394 397 399 403 406
    Diluted EPS Excluding Extraordinary Items 17.6396 19.4584 15.9774 9.19107 7.52463
    Dividends per Share - Common Stock Primary Issue 1.16 1 0.85 0.74 0.66
    Diluted Normalized EPS 18.0254 21.9169 16.1875 8.85233 7.73455
    Interest Expense (Income) - Net Operating -17 1 2
    Other Operating Expenses, Total 59 47
    Minority Interest -10 -3
    Equity In Affiliates -172 -4
    Jul 2023 Apr 2023 Dec 2022 Oct 2022 Jul 2022
    Total revenue 10687 10710 11450 10677 10970
    Revenue 10687 10710 11450 10677 10970
    Cost of Revenue, Total 6436 6570 6844 6375 6371
    Gross Profit 4251 4140 4606 4302 4599
    Total Operating Expense 9109 9147 9589 8967 8969
    Selling/General/Admin. Expenses, Total 2145 2119 2240 2208 2209
    Research & Development 345 346 391 351 365
    Unusual Expense (Income) 183 112 55 33 24
    Operating Income 1578 1563 1861 1710 2001
    Interest Income (Expense), Net Non-Operating -148 -198 -144 -118 -95
    Other, Net 0 -2 60 9 11
    Net Income Before Taxes 1430 1363 1777 1601 1917
    Net Income After Taxes 1378 1317 1604 1570 1719
    Net Income Before Extra. Items 1361 1289 1576 1495 1664
    Net Income 1361 1289 1576 1495 1664
    Income Available to Common Excl. Extra. Items 1361 1289 1576 1495 1664
    Income Available to Common Incl. Extra. Items 1361 1289 1576 1495 1664
    Diluted Net Income 1361 1289 1576 1495 1664
    Diluted Weighted Average Shares 388 388 392 395 394
    Diluted EPS Excluding Extraordinary Items 3.50773 3.32216 4.02041 3.78481 4.22335
    Dividends per Share - Common Stock Primary Issue 0.35 0.3 0.3 0.3 0.3
    Diluted Normalized EPS 3.9672 3.67828 4.15857 3.92135 4.27797
    Other Operating Expenses, Total 59
    Minority Interest -1 -3 2 -3 -4
    Equity In Affiliates -16 -25 -30 -72 -51
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total Current Assets 25229 20113 21957 11893 10625
    Cash and Short Term Investments 8526 4477 10353 2436 2134
    Cash & Equivalents 8524 4477 10325 2399 2103
    Short Term Investments 2 28 37 31
    Total Receivables, Net 9427 8945 6472 4952 4136
    Accounts Receivable - Trade, Net 9427 8945 6472 4952 4136
    Total Inventory 5634 5051 4029 3370 3005
    Other Current Assets, Total 1642 1640 1103 1135 1350
    Total Assets 97154 95123 69052 58381 56232
    Property/Plant/Equipment, Total - Net 10873 9864 6687 5448 4165
    Property/Plant/Equipment, Total - Gross 15862 14124 10352 8463 6820
    Accumulated Depreciation, Total -4989 -4260 -3665 -3015 -2655
    Goodwill, Net 41196 41924 26041 25714 25347
    Intangibles, Net 17442 20113 12685 14014 14978
    Other Long Term Assets, Total 2352 3087 1682 1312 1117
    Total Current Liabilities 17010 13436 10304 6197 6147
    Accounts Payable 3381 2867 2175 1920 1615
    Accrued Expenses 5433 5377 4098 2674 2436
    Notes Payable/Short Term Debt 310 2522 0 0 0
    Current Port. of LT Debt/Capital Leases 5269 15 2628 676 1271
    Other Current Liabilities, Total 2617 2655 1403 927 825
    Total Liabilities 53176 54330 34545 28706 28646
    Total Long Term Debt 28909 32333 19107 17076 17719
    Long Term Debt 28909 32333 19107 17076 17719
    Deferred Income Tax 2849 3837 1794 2192 2265
    Other Liabilities, Total 4238 4540 3340 3241 2515
    Total Equity 43978 40793 34507 29675 27586
    Common Stock 441 439 437 434 432
    Additional Paid-In Capital 16743 16174 15579 15064 14621
    Retained Earnings (Accumulated Deficit) 41910 35431 28116 22092 18696
    Treasury Stock - Common -12017 -8922 -6818 -5236 -3665
    Unrealized Gain (Loss) -33 -35 -91 -71 -52
    Other Equity, Total -3066 -2294 -2716 -2608 -2446
    Total Liabilities & Shareholders’ Equity 97154 95123 69052 58381 56232
    Total Common Shares Outstanding 390.511 394.435 396.671 398.74 402.122
    Long Term Investments 55 22
    Minority Interest 170 184
    Note Receivable - Long Term 7
    Apr 2023 Dec 2022 Oct 2022 Jul 2022 Apr 2022
    Total Current Assets 20209 25229 19299 18100 18776
    Cash and Short Term Investments 3482 8526 2941 1893 2758
    Cash & Equivalents 3482 8524 2919 1888 2752
    Short Term Investments 2 22 5 6
    Total Receivables, Net 9297 9427 8919 8892 8947
    Accounts Receivable - Trade, Net 9297 9427 8919 8892 8947
    Total Inventory 5664 5634 5722 5668 5483
    Other Current Assets, Total 1766 1642 1717 1647 1588
    Total Assets 94658 97154 90536 90579 92747
    Property/Plant/Equipment, Total - Net 9354 9280 8628 8529 8448
    Goodwill, Net 43140 41196 40488 41066 41721
    Intangibles, Net 17972 17442 17813 18578 19378
    Other Long Term Assets, Total 3975 4000 4299 4296 4413
    Total Current Liabilities 15884 17010 11118 10997 12070
    Accounts Payable 2798 3381 2471 2586 2667
    Accrued Expenses 4302 5433 5068 4678 4664
    Notes Payable/Short Term Debt 0 0 0 0 0
    Current Port. of LT Debt/Capital Leases 6122 5579 1010 1010 1866
    Other Current Liabilities, Total 2662 2617 2569 2723 2873
    Total Liabilities 52401 53176 46987 48286 51791
    Total Long Term Debt 29135 28909 28150 29250 30095
    Long Term Debt 29135 28909 28150 29250 30095
    Deferred Income Tax 2976 2849 3140 3327 3493
    Other Liabilities, Total 4230 4238 4401 4534 5958
    Total Equity 42257 43978 43549 42293 40956
    Common Stock 441 441 440 440 440
    Additional Paid-In Capital 16889 16743 16596 16467 16292
    Retained Earnings (Accumulated Deficit) 43064 41910 40452 39074 37528
    Treasury Stock - Common -15083 -12017 -11011 -10964 -10961
    Unrealized Gain (Loss) -30 -33 -33 -34 -34
    Other Equity, Total -3024 -3066 -2895 -2690 -2309
    Total Liabilities & Shareholders’ Equity 94658 97154 90536 90579 92747
    Total Common Shares Outstanding 385.721 390.511 392.196 391.789 391.439
    Property/Plant/Equipment, Total - Gross
    Accumulated Depreciation, Total
    Minority Interest 176 170 178 178 175
    Note Receivable - Long Term 8 7 9 10 11
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Net income/Starting Line 6960 7728 6375 3696 2938
    Cash From Operating Activities 9154 9312 8289 4973 4543
    Cash From Operating Activities 986 831 658 564 2267
    Deferred Taxes -995 -647 -552 -302 -379
    Non-Cash Items 857 1187 536 -33 287
    Changes in Working Capital -1049 -1548 -395 -665 -570
    Cash From Investing Activities -2159 -21932 -1510 -1487 -1253
    Capital Expenditures -2243 -2523 -1474 -926 -758
    Other Investing Cash Flow Items, Total 84 -19409 -36 -561 -495
    Cash From Financing Activities -2810 6581 959 -3118 -2237
    Financing Cash Flow Items -9 -91 -147 -69 -51
    Total Cash Dividends Paid -455 -395 -337 -297 -266
    Issuance (Retirement) of Stock, Net -3000 -1844 -1304 -1347 -364
    Issuance (Retirement) of Debt, Net 654 8911 2747 -1405 -1556
    Foreign Exchange Effects -139 194 176 -63 -297
    Net Change in Cash 4046 -5845 7914 305 756
    Cash Taxes Paid 1234 2182 1324 896 591
    Cash Interest Paid 667 555 471 790 687
    Amortization 2395 1761 1667 1713
    Apr 2023 Dec 2022 Oct 2022 Jul 2022 Apr 2022
    Net income/Starting Line 1292 6960 5386 3888 2220
    Cash From Operating Activities 729 9154 5667 3730 2202
    Cash From Operating Activities 253 986 730 486 250
    Amortization 606 2395 1803 1209 609
    Deferred Taxes -146 -995 -862 -601 -339
    Non-Cash Items 257 857 701 472 337
    Changes in Working Capital -1533 -1049 -2091 -1724 -875
    Cash From Investing Activities -3142 -2159 -1634 -1089 -670
    Capital Expenditures -458 -2243 -1693 -1146 -640
    Other Investing Cash Flow Items, Total -2684 84 59 57 -30
    Cash From Financing Activities -2593 -2810 -5201 -5050 -3145
    Financing Cash Flow Items 20 -9 -86 -48 -36
    Total Cash Dividends Paid -117 -455 -338 -220 -103
    Issuance (Retirement) of Stock, Net -3000 -3000 -1943 -1949 -1998
    Issuance (Retirement) of Debt, Net 504 654 -2834 -2833 -1008
    Foreign Exchange Effects -31 -139 -389 -177 -99
    Net Change in Cash -5037 4046 -1557 -2586 -1712
    Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
    The Vanguard Group, Inc. Investment Advisor/Hedge Fund 8.3978 32411301 3067 2023-06-30 LOW
    BlackRock Institutional Trust Company, N.A. Investment Advisor 4.7696 18408301 -388612 2023-06-30 LOW
    State Street Global Advisors (US) Investment Advisor/Hedge Fund 4.1759 16116956 55458 2023-06-30 LOW
    Capital World Investors Investment Advisor 3.3362 12876098 -48366 2023-06-30 LOW
    Fidelity Management & Research Company LLC Investment Advisor 2.2469 8672091 -2077992 2023-06-30 LOW
    T. Rowe Price Associates, Inc. Investment Advisor 2.2212 8572754 547312 2023-06-30 LOW
    Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 1.8082 6978869 -6715 2023-06-30 LOW
    MFS Investment Management Investment Advisor/Hedge Fund 1.6887 6517361 -1270699 2023-06-30 LOW
    Capital Research Global Investors Investment Advisor 1.5783 6091325 157512 2023-06-30 LOW
    Norges Bank Investment Management (NBIM) Sovereign Wealth Fund 1.4612 5639611 219567 2022-12-31 LOW
    Morgan Stanley Smith Barney LLC Investment Advisor 1.1087 4278887 209573 2023-06-30 LOW
    Morgan Stanley Investment Management Ltd. (UK) Investment Advisor 1.0313 3980403 378915 2023-06-30 LOW
    TCI Fund Management Limited Hedge Fund 0.8222 3173182 2339032 2023-06-30 LOW
    Arthur M. Cohen & Associates, LLC Investment Advisor 0.8094 3124051 3113975 2023-06-30 MED
    BlackRock Investment Management (UK) Ltd. Investment Advisor/Hedge Fund 0.8035 3100948 -193634 2023-06-30 LOW
    PRIMECAP Management Company Investment Advisor 0.7975 3078107 -486002 2023-06-30 LOW
    JP Morgan Asset Management Investment Advisor 0.7742 2987984 -243076 2023-06-30 LOW
    Wellington Management Company, LLP Investment Advisor/Hedge Fund 0.7271 2806223 -83893 2023-06-30 LOW
    BofA Global Research (US) Research Firm 0.7041 2717630 -367618 2023-06-30 LOW
    Legal & General Investment Management Ltd. Investment Advisor/Hedge Fund 0.6763 2610108 50802 2023-06-30 LOW

    Trading calculator

    Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

    Trade commission
    0
    • 1:1
    Leverage
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investment
    Trade size (Leverage x Investement):
    Open

    Close

    Short Long
    Past performance is not a reliable indicator of future results For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)
    Profit/Loss

    For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

    Thermo Fisher Company profile

    Thermo Fisher Scientific Inc. (TMO) is a supplier of scientific laboratory products, instruments, software and other tools. The company was formed in a tax-free stock-for-stock merger of Thermo Electron Corporation with Fisher Scientific International Inc. in 2006. 

    The company provides services through various brands including Thermo Fishers, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. 

    Thermo Fisher works on accelerating life sciences research by solving complex analytical challenges. Its products aim to increase productivity in laboratories and improve patient health through diagnostics and therapy development. 

    The four segments that Thermo Fisher Scientific caters to are industrial and applied research, diagnostics and healthcare, academic and government research, and pharmaceuticals and biotechnology. 

    As of June 2022, Thermo Fisher has developed Orbitrap Exploris MX mass spectrometer, cell therapy workflow solutions, Oncomine Dx Target Test and several other solutions that aim to make the diagnosis of infections and diseases easier and enable production of drugs and vaccines. 

    Thermo Fisher Scientific Inc. stock is trading on the New York Stock Exchange (NYSE) under the ticker symbol TMO. You can follow live TMO stock movement and price history, and stay on top of the latest TMO share value at Capital.com.

    Industry: Advanced Medical Equipment & Technology (NEC)

    168 Third Avenue
    WALTHAM
    MASSACHUSETTS 02451
    US

    Income Statement

    • Annual
    • Quarterly

    News

    How to Trade The Triple Top

    Welcome to Part 5 of our 7-part Power Patterns series. In this series, we'll be equipping you with the skills to trade some of the most indicative price patterns which occur on any timeframe in every market.

    14:13, 27 September 2023
    USA flag on the background of stock charts. Financial system in USA

    Q4 lookahead: US indices starting to show signs of trouble?

    US indices start to draw attention as traders focus on the outlook for Q4.

    07:20, 27 September 2023

    USD/JPY Climbs Towards Key Highs

    USDJPY’s powerful long-term uptrend has been reignited after last week’s sharply contrasting policy statements from the Federal Reserve and Bank of Japan.

    11:32, 26 September 2023

    EUR/USD tests key support

    EUR/USD is currently testing a key support level after the Federal Reserve indicated a potential extension of higher interest rates.

    14:32, 21 September 2023
    Bank of England building

    BoE leaves rates unchanged, GBP drops further as investors look for more clarity

    The Bank of England has left rates unchanged at 5.25% with a 5-4 vote split after CPI dropped more than expected in August

    11:45, 21 September 2023
    British banknotes and coins photographed directly above. The coins are in a stack, placed on top of the banknotes.

    GBP softer after CPI surprise, JPY focused on any further hints from Ueda

    GBP drops after a softer CPI reading scares investors about the BoE intentions. JPY on the lookout for further policy tweaks from Governor Ueda.

    12:42, 20 September 2023

    How to Trade The Break & Retest

    In this week's instalment, we delve into the Break & Retest pattern—a strategic approach to navigating breakout trades. If you've wrestled with the frustration of false breakouts, incorporating this pattern into your trading toolkit may help you overcome this challenge and put you on the path to becoming a more confident and consistent trader.

    11:59, 20 September 2023

    People also watch

    US100

    14,567.50 Price
    +0.080% 1D Chg, %
    Long position overnight fee -0.0262%
    Short position overnight fee 0.0039%
    Overnight fee time 21:00 (UTC)
    Spread 1.8

    ETH/USD

    1,601.38 Price
    +0.850% 1D Chg, %
    Long position overnight fee -0.0616%
    Short position overnight fee 0.0137%
    Overnight fee time 21:00 (UTC)
    Spread 5.40

    Oil - Crude

    92.79 Price
    +2.930% 1D Chg, %
    Long position overnight fee 0.0436%
    Short position overnight fee -0.0655%
    Overnight fee time 21:00 (UTC)
    Spread 0.030

    XRP/USD

    0.51 Price
    -0.040% 1D Chg, %
    Long position overnight fee -0.0753%
    Short position overnight fee 0.0069%
    Overnight fee time 21:00 (UTC)
    Spread 0.01192

    Still looking for a broker you can trust?

    Join the 555.000+ traders worldwide that chose to trade with Capital.com

    1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading